###begin article-title 0
TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys
###end article-title 0
###begin p 1
Conceived and designed the experiments: SYL TR JS NLL. Performed the experiments: SYL TC JBW JK. Analyzed the data: SYL JS NLL. Contributed reagents/materials/analysis tools: JBW. Wrote the paper: SYL.
###end p 1
###begin p 2
###xml 471 476 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 728 733 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 796 804 780 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 844 851 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 967 975 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1066 1073 1046 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1330 1335 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 494 508 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 528 557 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 559 562 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 782 785 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 830 833 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1281 1295 <span type="species:ncbi:9544">rhesus monkeys</span>
The cytoplasmic TRIM5alpha proteins of certain mammalian lineages efficiently recognize the incoming capsids of particular retroviruses and potently restrict infection in a species-specific manner. Successful retroviruses have evolved capsids that are less efficiently recognized by the TRIM5alpha proteins of the natural hosts. To address whether TRIM5alpha contributes to the outcome of retroviral infection in a susceptible host species, we investigated the impact of TRIM5 polymorphisms in rhesus monkeys on the course of a simian immunodeficiency virus (SIV) infection. Full-length TRIM5alpha cDNAs were derived from each of 79 outbred monkeys and sequenced. Associations were explored between the expression of particular TRIM5 alleles and both the permissiveness of cells to SIV infection in vitro and clinical sequelae of SIV infection in vivo. Natural variation in the TRIM5alpha B30.2(SPRY) domain influenced the efficiency of SIVmac capsid binding and the in vitro susceptibility of cells from the monkeys to SIVmac infection. We also show the importance in vivo of the interaction of SIVmac with different allelic forms of TRIM5, demonstrating that particular alleles are associated with as much as 1.3 median log difference in set-point viral loads in SIVmac-infected rhesus monkeys. Moreover, these allelic forms of TRIM5 were associated with the extent of loss of central memory (CM) CD4+ T cells and the rate of progression to AIDS in the infected monkeys. These findings demonstrate a central role for TRIM5alpha in limiting the replication of an immunodeficiency virus infection in a primate host.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 376 383 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 490 497 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 347 350 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 563 566 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 784 787 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 877 880 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1081 1091 <span type="species:ncbi:12721">AIDS virus</span>
###xml 1176 1186 <span type="species:ncbi:12721">AIDS virus</span>
The cytoplasmic TRIM5alpha restricts the replication of a broad range of retroviruses in a species-specific manner. In the present study we show that TRIM5alpha is more than a species barrier for retroviruses. We show that naturally occurring B30.2(SPRY) polymorphisms affect retrovirus infection. These observations demonstrate the importance of SIV/B30.2(SPRY) interactions in vivo. These findings are the first demonstration of the importance of such a pathogen/host protein interaction in vivo. Importantly, the striking variability in the clinical course of HIV-infected individuals has long puzzled the biomedical community. A large number of investigators have devoted considerable effort to determine what genetically determined factors might contribute to the containment of HIV replication, reasoning that an understanding of the determinants of effective control of HIV spread will provide important targets for both drug and vaccine development. Our demonstration in the present study that B30.2(SPRY) polymorphisms have a dramatic effect on the clinical outcome of an AIDS virus infection highlight the extraordinary importance of TRIM5alpha on the control of an AIDS virus infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 166 169 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Hatziioannou1">[1]</xref>
###xml 170 173 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Perron1">[5]</xref>
###xml 317 325 305 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 325 328 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Stremlau1">[4]</xref>
###xml 402 405 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Hatziioannou1">[1]</xref>
###xml 406 409 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Yap1">[3]</xref>
###xml 410 413 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Perron1">[5]</xref>
###xml 697 700 665 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Yap1">[3]</xref>
###xml 701 704 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Perron1">[5]</xref>
###xml 705 708 673 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Richardson1">[6]</xref>
###xml 709 712 677 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Song1">[7]</xref>
###xml 723 728 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 835 838 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Newman1">[8]</xref>
###xml 839 842 807 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Wilson1">[9]</xref>
###xml 957 965 921 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1072 1077 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1128 1135 1092 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 202 216 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 256 261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 301 304 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 384 389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 800 814 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 819 834 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 988 993 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1112 1115 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The cytoplasmic tripartite motif protein 5alpha (TRIM5alpha) has been shown to restrict the replication of a broad range of retroviruses in a species-specific manner [1]-[5]. For example, TRIM5alpha of rhesus monkeys mediates an early, post-entry block of HIV-1 replication but only a modest block of SIV replication in vitro[4], whereas human TRIM5alpha restricts N-MLV potently but HIV-1 only weakly [1]-[3],[5]. Although primate TRIM5alpha variants share a similar domain organization, TRIM5alpha sequences are highly polymorphic in different species; this interspecies sequence variation of TRIM5alpha is associated with differences in the viral specificity of TRIM5alpha-mediated restriction [3],[5],[6],[7]. Multiple TRIM5 alleles have been recently identified in Old World primates, including rhesus monkeys and sooty mangabeys [8],[9]. While a few of these polymorphic forms of TRIM5alpha have an effect on the susceptibility of transduced cells to in vitro retrovirus infection (HIV-1 and N-MLV), no significant association has been observed between any of these TRIM5 alleles and either the control of SIV replication in vivo or AIDS pathogenesis.
###end p 6
###begin p 7
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Ourmanov1">[10]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Yasutomi1">[12]</xref>
###xml 611 618 611 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Pal1">[13]</xref>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 984 991 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Goldstein1">[14]</xref>
###xml 1112 1117 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 53 67 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 114 117 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 196 199 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 209 222 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 421 424 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 433 447 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 463 477 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 595 598 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 658 661 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 799 802 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 909 912 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 956 959 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1026 1029 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1158 1161 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1191 1205 <span type="species:ncbi:9544">rhesus monkeys</span>
Although they are resistant to infection with HIV-1, rhesus monkeys support the replication of certain strains of SIV and develop an AIDS-like disease following infection with these isolates. The SIV-infected rhesus monkey has become an invaluable model for studying AIDS pathogenesis and evaluating AIDS vaccine strategies [10]-[12]. Interestingly, high levels of viral replication are achieved following infection with SIV in some rhesus monkeys, whereas other rhesus monkeys appear to be more resistant to infection. Certain MHC class I alleles have been associated with efficient control of SIV replication in vivo on the basis of particularly effective SIV-specific cytotoxic T lymphocyte responses [13]. Factors other than adaptive immune responses also have been implicated in the control of SIV replication, since the relative permissivity of a monkey's peripheral blood mononuclear cells (PBMCs) for SIV replication in vitro predicts the level of SIV replication that occurs in vivo when that monkey is infected with SIV [14]. The present study was initiated to explore the contribution of intraspecies TRIM5 allelic polymorphisms to the control of SIV replication in Indian-origin rhesus monkeys.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 14 27 <span type="species:ncbi:9544">rhesus monkey</span>
Sequencing of rhesus monkey TRIM5alpha
###end title 9
###begin p 10
###xml 71 76 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 493 499 489 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g001">Fig. 1</xref>
###xml 713 718 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 908 913 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1045 1052 1041 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000738-t001">Table 1</xref>
###xml 1388 1392 1380 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Brennan1">[15]</xref>
###xml 1393 1397 1385 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Wilson2">[18]</xref>
###xml 43 57 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 142 156 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 477 491 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 894 907 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1182 1195 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1439 1453 <span type="species:ncbi:9544">rhesus monkeys</span>
To characterize the TRIM5alpha variants of rhesus monkeys, full-length TRIM5 cDNAs were derived and sequenced from 79 unrelated Indian-origin rhesus monkeys. Six to 15 independent cDNA clones from each monkey were sequenced. Genomic DNAs from these same animals were also sequenced to confirm the identity of these alleles. We identified a 2-amino acid deletion and 14 single nucleotide polymorphisms (SNPs), each of which was present in at least two animals in this cohort of rhesus monkeys (Fig. 1). The 2-amino acid deletion and most of the nonsynonymous SNPs (nsSNPs) clustered in the coiled-coil (CC) and the B30.2(SPRY) domains of the molecule. An allele was identified with a nsSNP in the L2 linker, and 4 TRIM5 alleles were also characterized that had synonymous polymorphisms clustered in the CC and B30.2(SPRY) regions of the molecule. Based on the distribution of the 10 nsSNPs, the rhesus monkey TRIM5 coding sequences were grouped into 12 distinct alleles. These alleles and their frequencies in a cohort of 79 monkeys are shown in Table 1, ordered according to increasing numbers of nsSNPs. The predicted amino acid sequence of allele 1 was identical to the published rhesus monkey TRIM5alpha sequence (AY625001), and the predicted sequence of allele 11 was most divergent from allele 1. TRIMCyp, a molecule in which the TRIM5 RBCC domains are fused to cyclophilin A (CypA) [15]-[18], was cloned from cDNAs prepared from the rhesus monkeys and is designated as allele 12. The coincident expression of two different alleles was observed in many of the monkeys.
###end p 10
###begin title 11
A schematic illustrating TRIM5alpha and its functional domains.
###end title 11
###begin p 12
The major domains of TRIM5alpha are shaded in light grey, and the linker 1 (L1) and linker 2 (L2) regions are designated. The dark grey boxes correspond to variable regions (V1-V4) in the B30.2 (SPRY) domain of the molecule. Locations of coding SNPs are indicated by vertical lines. Nonsynonymous (ns) SNPs with corresponding amino acid changes relative to the major allele are shown above and synonymous SNPs are indicated below by asterisks. These alleles were defined by sequencing full-length cDNA and genomic DNA generated from either B-lymphoblastoid cell lines (B-LCL) or PBMCs of these monkeys.
###end p 12
###begin title 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 53 67 <span type="species:ncbi:9544">rhesus monkeys</span>
TRIM5 alleles and their frequencies in Indian-origin rhesus monkeys.
###end title 13
###begin p 14
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 71 84 <span type="species:ncbi:9544">rhesus monkey</span>
DNA sequences were aligned with the published sequence of TRIM5 of the rhesus monkey fibroblast cell line (AY625001). Nucleotide (nt) changes are shown for each allele. Deletions are indicated by dashes.
###end p 14
###begin p 15
Predicted amino acid (AA) substitutions for nonsynonymous coding SNPs. The amino acid encoded by the predominant allele precedes the residue number, which is followed by the amino acid encoded by the minor allele. Deletions are indicated by Delta.
###end p 15
###begin p 16
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 57 71 <span type="species:ncbi:9544">rhesus monkeys</span>
Frequency of TRIM5 alleles in 79 evaluated Indian-origin rhesus monkeys.
###end p 16
###begin p 17
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Brennan1">[15]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Wilson2">[18]</xref>
###xml 128 141 <span type="species:ncbi:9544">rhesus monkey</span>
TRIMCyp, a molecule in which the TRIM5 RBCC domain is fused to CypA [15]-[18], was cloned and sequenced from cDNA prepared from rhesus monkey lymphocytes.
###end p 17
###begin title 18
###xml 73 76 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
TRIM5alpha polymorphisms are associated with susceptibility of B-LCLs to SIV infection
###end title 18
###begin p 19
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 306 311 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 346 354 342 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 443 448 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 564 572 560 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 673 678 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 704 717 700 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g002">Fig. 2A and B</xref>
###xml 837 838 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1001 1006 997 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1017 1024 1013 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000738-t002">Table 2</xref>
###xml 1063 1068 1059 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1795 1802 1783 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g002">Fig. 2C</xref>
###xml 44 57 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 123 126 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 373 386 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 477 503 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 614 627 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1027 1040 <span type="species:ncbi:9544">Rhesus monkey</span>
We then sought to assess the impact of this rhesus monkey TRIM5 allelic diversity on the susceptibility of monkey cells to SIV infection. Since TRIM5alpha restricts the replication of retroviruses by interfering with a post-entry step in their life cycle, we chose first to evaluate the effect of specific TRIM5 allelic products by assessing the in vitro susceptibility of rhesus monkey B-lymphoblastoid cell lines (B-LCLs) expressing defined TRIM5 alleles to infection with a vesicular stomatitis virus G (VSV-G)-pseudotyped SIVmac239-GFP construct. The relative in vitro susceptibility to SIVmac239 infection of rhesus monkey B-LCLs expressing homozygous or heterozygous TRIM5 alleles 1-11 is shown in Fig. 2A and B. A significant variation in susceptibility to SIVmac239 infection was observed among these genetically diverse B-LCLs (P = 0.0164). We then used a Dunn's post test to compare the relative permissiveness for infection of each group of B-LCLs to that of the B-LCLs that expressed only TRIM5 allele 1 (Table 2). Rhesus monkey B-LCLs homozygous for TRIM5 alleles 7, 9 and 10 were significantly more permissive for SIVmac239 infection. The TRIM5alpha proteins encoded by these alleles share identical B30.2(SPRY) domain residues 328-497. These amino acid residues are also shared by TRIM5alpha products of alleles 6, 8 and 11. Our inability to demonstrate statistically significant increased permissiveness of alleles 6, 8, and 11 for SIVmac239 infection may be a consequence of the small number of B-LCL populations for evaluation. In fact, when these B-LCLs were assigned to 3 groups on the basis of homozygosity or heterozygosity for expression of alleles 1-5 or 6-11, a statistically significant difference in the permissivity of the cells for SIVmac239 infection was observed (Fig. 2C).
###end p 19
###begin title 20
Effect of TRIM5alpha variants on susceptibility of B-LCLs to SIVmac239 infection.
###end title 20
###begin p 21
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 40 53 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 827 840 <span type="species:ncbi:9544">rhesus monkey</span>
The TRIM5 alleles expressed by selected rhesus monkey B-LCLs were first characterized by cDNA sequencing. These B-LCLs were then evaluated for their relative susceptibility to SIVmac239 replication by incubation for 48 h with a VSV-G-pseudotyped SIVmac239-GFP construct. The percentage of cells expressing GFP was assessed by flow cytometric analysis in B-LCLs homozygous (A) or heterozygous (B) for TRIM5 alleles 1-11. The B-LCLs were then divided into three groups: "1-5/1-5" expressing only TRIM5 alleles 1-5; "1-5/6-11" expressing a TRIM5 allele from the 1-5 groups and another from the 6-11 groups, "6-11/6-11" expressing only TRIM5 alleles 6-11 (C). The sequences of amino acid residues 328-479 of the TRIM5alpha B30.2 (SPRY) domain encoded by alleles 1-5 are identical to each other and to those previously described as rhesus monkey TRIM5alpha (AY625001). In contrast, a 2-amino acid deletion (339-340) and 3 nsSNPs (A333S, P341Q and S422L) are present in the B30.2 (SPRY) domain of TRIM5alpha variants encoded by alleles 6-11. The comparison of the values from the 3 groups of B-LCL was analyzed using a non-parametric one-way ANOVA Kruskal-Wallis test with a Dunn's multiple comparison test.
###end p 21
###begin title 22
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 36 49 <span type="species:ncbi:9544">rhesus monkey</span>
Comparison of the % GFP values from rhesus monkey B-LCLs expressing various combinations of TRIM5 alleles with a control group of B-LCLs expressing only the TRIM5 allele 1.
###end title 22
###begin p 23
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
Dunn's multiple comparison test was applied to assess the significance of the difference in GFP expression between each of the groups of B-LCLs and the TRIM5 allele 1 homozygous B-LCLs.
###end p 23
###begin p 24
###xml 59 72 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 402 415 <span type="species:ncbi:9544">rhesus monkey</span>
The observation above suggested that the permissiveness of rhesus monkey B-LCLs for SIVmac239 replication was associated with amino acid changes clustered in the B30.2(SPRY) domain of TRIM5alpha. The TRIM5alpha proteins encoded by the more restricted alleles 1-5 are identical in amino acid residues 328-497 in the B30.2(SPRY) domain. These sequences are also identical to that previously described as rhesus monkey TRIM5alpha AY625001. Interestingly, alleles 6-11 are all identical in residues 328-497 of the B30.2(SPRY) domain, but differ from alleles 1-5 because of a 2-amino acid deletion (339-340) and 3 nsSNPs (A333S, P341Q and S422L). The results suggest that amino acid changes in the region including residues 328-497 of the TRIM5alpha B30.2(SPRY) domain determine the efficiency of TRIM5alpha-mediated restriction for SIVmac239 replication in B-LCLs.
###end p 24
###begin title 25
Effects of TRIM5alpha polymorphisms on retrovirus infections
###end title 25
###begin p 26
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 476 486 472 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g003">Fig. 3A, B</xref>
###xml 1086 1091 1078 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1101 1110 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g003">Fig. 3C&#8211;F</xref>
###xml 89 102 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 516 521 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 576 589 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 671 684 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 730 735 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 864 894 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 896 900 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 903 932 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 934 937 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 949 970 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 992 1013 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 1139 1152 <span type="species:ncbi:9544">rhesus monkey</span>
A number of other complementing observations were made in studying the permissiveness of rhesus monkey B-LCLs assigned to 2 groups on the basis of homozygosity for expression of alleles 1-5 or 6-11 to retrovirus infection. We found that B-LCLs expressing only TRIM5 alleles 1-5 efficiently restricted SIVsmE543 and HIV-1 infection, whereas B-LCLs expressing only TRIM5alpha molecule from the group of alleles 6-11 were more permissive for infection by these virus constructs (Fig. 3A, B). The overall infectivity of HIV-1 was substantially lower than that of SIVmac239 in the rhesus monkey B-LCLs. This likely reflects the fact that, even in B-LCLs bearing alleles 6-11, rhesus monkey TRIM5alpha provides a significant barrier to HIV-1 infection. In contrast to this finding, no significant differences in susceptibility to infection by other retroviruses such as equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), N-tropic murine leukemia virus (N-MLV) and B-tropic murine leukemia virus (B-MLV) were found between B-LCLs expressing one or the other groups of TRIM5 alleles (Fig. 3C-F). These results suggest the rhesus monkey TRIM5alpha polymorphisms specifically influence restriction potency for a subset of retroviruses that includes the primate immunodeficiency viruses (PIVs).
###end p 26
###begin title 27
###xml 52 65 <span type="species:ncbi:9544">rhesus monkey</span>
Effects of TRIM5alpha variants on susceptibility of rhesus monkey B-LCLs to VSV-G-pseudotyped retrovirus constructs.
###end title 27
###begin p 28
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 0 13 <span type="species:ncbi:9544">Rhesus monkey</span>
###xml 334 339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 349 353 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 363 366 <span type="species:ncbi:11673?1.0">FIV</span>
Rhesus monkey B-LCLs expressing selected TRIM5 alleles were divided into two groups, one expressing only TRIM5 alleles 1-5, and the other expressing only TRIM5 alleles 6-11. They were then evaluated for their relative susceptibility to retrovirus infection by incubation for 48 h with VSV-G-pseudotyped recombinant SIVsmE543-GFP (A), HIV-1-GFP (B), EIAV-GFP (C), FIV-GFP (D), N-MLV-GFP (E) or B-MLV-GFP (F) and assessed for % of cells expressing GFP by flow cytometric analysis. The comparison of the values from the 2 groups of B-LCL was analyzed using the Mann-Whitney test.
###end p 28
###begin title 29
TRIM5 allelic variants differ in their ability to restrict VSV-G-pseudotyped SIVmac239-GFP infection of feline fibroblasts
###end title 29
###begin p 30
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 894 901 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g004">Fig. 4A</xref>
###xml 1208 1215 1200 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g004">Fig. 4A</xref>
###xml 1255 1260 1247 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1327 1332 1319 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1393 1400 1385 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g004">Fig. 4B</xref>
###xml 1465 1472 1457 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g004">Fig. 4B</xref>
###xml 2229 2236 2201 2208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000738-t001">Table 1</xref>
###xml 29 42 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 984 989 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 991 995 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 997 1000 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1088 1093 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1292 1296 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1298 1301 <span type="species:ncbi:11673?1.0">FIV</span>
The contribution of specific rhesus monkey TRIM5 alleles to the inhibition of SIVmac infection was also assessed in TRIM5-transduced cell lines. Feline renal fibroblast (CRFK) cells were stably transduced to express TRIM5alpha variants encoded by alleles 1, 5, 7 or 11. To produce recombinant viruses, we co-transfected 293T cells with the pLPCX vectors expressing each TRIM5alpha variant with pVpack-GP and pVPack-VSV-G packaging plasmids. CRFK cells were transduced using the resulting viruses and then selected in G418. These transduced cells were infected with a VSV-G-pseudotyped SIVmac239-GFP construct and subjected to flow cytometric analysis. Consistent with the studies of the B-LCLs, we found that cells transduced with allele 1 or 5 supported a lower level of infection by SIVmac239-GFP, whereas cells transduced with allele 7 or 11 supported a higher level of SIVmac239 infection (Fig. 4A). We also assessed the infectivity of VSV-G-pseudotyped GFP-expressing SIVsmE543, HIV-1, EIAV, FIV, N-MLV and B-MLV viruses these same transduced cells. The restriction of SIVsmE543 and HIV-1 infection was more efficient in cells transduced with allele 1 or 5 than in cells transduced with allele 7 or 11 (Fig. 4A). While transduction of cells with the TRIM5 alleles inhibited infection by EIAV, FIV and N-MLV, all evaluated TRIM5 alleles inhibited the infection with comparable efficiency (Fig. 4B). Expression of these alleles did not restrict B-MLV infection (Fig. 4B). We verified that the HA epitope tag at the C terminus of the TRIM5alpha protein did not affect the ability of transduced cells to restrict SIVmac239 infection (data not shown). We also confirmed that downregulation of TRIM5alpha expression by siRNA specifically rescued the infectivity of the restricted SIVmac239 (data not shown). Since the level of TRIM5alpha protein expression in each of the transduced cells was comparable as determined by Western blotting, differences in TRIM5alpha protein expression level could not account for the observed differences in the ability of the cells to restrict SIVmac239 infection. The TRIM5alpha proteins encoded by allele 1 and 7, and by alleles 5 and 11, differ only in the sequences of the B30.2(SPRY) domain (Table 1). Therefore, as in the studies of B-LCLs, the permissiveness for SIVmac replication in the transduced cells was associated with amino acid changes clustered in the B30.2(SPRY) domain of TRIM5alpha.
###end p 30
###begin title 31
Antiretroviral activity of TRIM5alpha variants expressed in feline renal fibroblast (CRFK) cells.
###end title 31
###begin p 32
###xml 433 438 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 566 571 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 755 759 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 765 768 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 938 942 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 948 951 <span type="species:ncbi:11673?1.0">FIV</span>
Feline renal fibroblast (CRFK) cells stably expressing TRIM5alpha variants encoded by allele 1, 5, 7 or 11, or control cells transduced with the empty pLPCX vector were incubated with a VSV-G-pseudotyped recombinant virus construct for 48 h and then subjected to flow cytometric analysis. (A) To assess the effects of TRIM5alpha variants on the infection of primate immunodeficiency viruses (PIVs), SIVmac239-GFP, SIVsmE543-GFP, and HIV-1-GFP were tested. The results of a repeat experiment are shown. Six dilutions of the stock of SIVmac239-GFP, SIVsmE543-GFP, and HIV-1-GFP were used to infect the transduced cell lines. (B) CRFK cells expressing different TRIM5alpha variants or control cells transduced with the empty pLPCX vector were incubated with EIAV-GFP, FIV-GFP, N-MLV-GFP or B-MLV-GFP. Infected GFP-positive cells were assessed by flow cytometric analysis. Represent data from repeated experiments are shown. Six dilutions of EIAV-GFP, FIV-GFP, N-MLV-GFP, and B-MLV-GFP were used to achieve 100% transduction of the control cells with the empty pLPCX vector. (C) The expression of TRIM5alpha protein by the transduced cells was determined by Western blotting using an anti-HA antibody. Levels of beta-actin were also assessed as a control for the loading of total protein.
###end p 32
###begin title 33
Effects of TRIM5alpha polymorphisms on SIVmac239 capsid binding
###end title 33
###begin p 34
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 273 277 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Stremlau2">[19]</xref>
###xml 278 282 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Javanbakht1">[21]</xref>
###xml 719 724 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 866 869 842 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Stremlau1">[4]</xref>
###xml 1000 1007 972 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000738-t001">Table 1</xref>
###xml 408 421 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 841 854 <span type="species:ncbi:9544">rhesus monkey</span>
We then explored the mechanism accounting for the differences in efficiency of restriction of SIVmac239 infection mediated by these different TRIM5 alleles. A direct interaction of TRIM5alpha with the retroviral capsid is required for restriction of retrovirus replication [19]-[21]. The recognition of the capsid by TRIM5alpha is mediated by the B30.2(SPRY) domain. Because the phenotypic differences among rhesus monkey TRIM5alpha variants grouped according to the sequence of the B30.2(SPRY) domain, we hypothesized that the two groups of TRIM5alpha variants might exhibit differences in the ability to bind SIVmac capsids. Two TRIM5alpha proteins encoded by alleles 1 and 7 were studied for capsid-binding ability. TRIM5 allele 1 represents the major allele and encodes a protein identical in sequence to that of the previously reported rhesus monkey TRIM5alpha [4]. The TRIM5alpha protein encoded by allele 7 differs from that encoded by allele 1 only in the sequence of the B30.2(SPRY) domain (Table 1). Therefore, TRIM5alpha variants 1 and 7 were chosen as representatives of the two groups of TRIM5alpha B30.2(SPRY) domain variants and tested for their ability to bind SIVmac capsid.
###end p 34
###begin p 35
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 131 135 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Ganser1">[22]</xref>
###xml 214 222 210 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 661 665 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-DiazGriffero1">[23]</xref>
###xml 845 850 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 925 935 897 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g005">Fig. 5A, B</xref>
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 621 626 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For this purpose, we adapted an in vitro capsid-binding assay, which has been used to study TRIM5alpha binding to the HIV-1 capsid [22]. In our assay, SIVmac239 capsid-nucleocapsid (CA-NC) complexes were generated in vitro, and then incubated with serial dilutions of 293T cell lysates containing TRIM5alpha allelic variants 1 and 7. After incubation, TRIM5alpha protein bound to CA-NC complexes was separated from unbound TRIM5alpha by pelleting through a sucrose cushion. The amount of TRIM5alpha in both input and pellet was analyzed by Western blotting and densitometry. As expected from previous experience with the HIV-1 capsid-nucleocapsid binding assay [23], both TRIM5alpha allelic variants bound the SIVmac239 CA-NC complexes in a dose-dependent manner with a sigmoidal pattern. Importantly, however, binding of the variant encoded by TRIM5 allele 7 was less efficient than that of the TRIM5alpha allele 1 variant (Fig. 5A, B). This finding is consistent with the possibility that differences in the efficiency of binding the SIVmac239 capsid contribute to the observed differences in SIVmac239 restriction potency, with the less efficiently binding allelic variant 7 mediating the less potent restriction of viral replication.
###end p 35
###begin title 36
Effect of TRIM5alpha variation on SIVmac239 capsid binding.
###end title 36
###begin p 37
###xml 185 193 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Serial dilutions of 293T cell lysates (input) containing TRIM5alpha-HA proteins encoded by allele 1 or allele 7 were incubated with equal amounts of SIVmac239 CA-NC complexes assembled in vitro. After incubation, the mixtures were pelleted through a sucrose cushion. The amounts of TRIM5alpha in both input and pellet were subjected to Western blotting and densitometry. The results of two separate experiments are shown. The Western blot (A) of experiment 1 was quantitatively analyzed by a densitometer with the results shown in (B). The last two samples of the allele 7 variant were beyond the linear range of the densitometry and, therefore, were not included in the final analysis in (B). Both pellet and input amounts are shown in arbitrary densitometric units.
###end p 37
###begin title 38
TRIM5alpha polymorphisms are associated with plasma viral RNA levels and clinical sequelae of SIVmac251 infection
###end title 38
###begin p 39
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 434 441 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 502 507 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 766 775 762 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mamu-A*01</italic>
###xml 777 782 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-B*08</italic>
###xml 784 792 780 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">or -B*17</italic>
###xml 883 887 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Loffredo1">[24]</xref>
###xml 888 892 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Moth1">[26]</xref>
###xml 202 216 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 867 870 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
To determine the ramifications of these in vitro findings for the control of viral replication in vivo, a study was done to determine whether the expression of particular TRIM5 alleles by Indian-origin rhesus monkeys was associated with the in vivo control of SIVmac251 replication. We tested the specific hypothesis that variation in residues 328-497 of the TRIM5alpha B30.2(SPRY) domain influences the course of SIVmac251 infection in vivo. The monkeys were divided into 3 groups: in one group, only TRIM5 alleles 1-5 were expressed; in the second group, one copy of alleles 1-5 and one copy of alleles 6-11 were expressed; and in the third group, only alleles 6-11 were expressed. Monkeys were selected for this study that did not express the MHC class I alleles Mamu-A*01, -B*08, or -B*17, as their expression is associated with particularly efficient control of SIV replication [24]-[26]. Eliminating these monkeys from the evaluated animals eliminated an already defined source of variation in virus control.
###end p 39
###begin p 40
###xml 555 562 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g006">Fig. 6A</xref>
###xml 760 768 760 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 807 812 807 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 945 952 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1282 1289 1282 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g006">Fig. 6A</xref>
###xml 1523 1530 1523 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g006">Fig. 6A</xref>
###xml 7 10 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 54 68 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 218 221 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 626 640 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 871 885 <span type="species:ncbi:9544">rhesus monkeys</span>
Plasma SIV RNA levels were assessed in this cohort of rhesus monkeys through day 178 after SIVmac251 challenge. We measured viral replication for each monkey by doing an area-under-the curve calculation for the plasma SIV RNA levels between days 1 and 70 following infection. A 0.1 log median difference in these values was observed between the allele 1-5 homozygous and the allele 1-5/allele 6-11 heterozygous monkeys, and a 0.6 log median difference in these values was observed between the allele 1-5 homozygous and the allele 6-11 homozygous monkeys (Fig. 6A). Plasma virus RNA levels were also assessed in this cohort of rhesus monkeys on days 14 (peak) and 70 (set-point) following the intravenous inoculation of SIVmac251. Consistent with the decreased in vitro antiviral activity of the products of TRIM5 alleles 6-11, the expression of TRIM5 alleles 6-11 by the rhesus monkeys was associated with higher levels of SIVmac251 replication in vivo. A 0.4 log median difference in plasma virus RNA levels at the time of peak viral replication was observed between the allele 1-5 homozygous and the allele 1-5/allele 6-11 heterozygous monkeys, and a 0.6 log median difference in these values was observed between the allele 1-5 homozygous and the allele 6-11 homozygous monkeys (Fig. 6A). A log median difference in set-point virus RNA levels was 0.7 between the allele 1-5 homozygous and the allele 1-5/allele 6-11 heterozygous monkeys, and 1.3 between the allele 1-5 homozygous and the allele 6-11 homozygous monkeys (Fig. 6A).
###end p 40
###begin title 41
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 60 74 <span type="species:ncbi:9544">rhesus monkeys</span>
Association of the expression of groups of TRIM5 alleles by rhesus monkeys with viral replication following SIVmac251 infection.
###end title 41
###begin p 42
###xml 609 615 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g002">Fig. 2</xref>
###xml 873 874 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 71 85 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 175 178 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 233 236 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 468 482 <span type="species:ncbi:9544">rhesus monkeys</span>
(A) Plasma virus RNA levels were assessed in a cohort of Indian-origin rhesus monkeys between days 1 and 178 after challenge. Area-under-the curve calculations for the plasma SIV RNA levels were assessed in these monkeys. The plasma SIV RNA levels were also assessed on days 14 and 70 following challenge, representing peak and set-point viral load, respectively. (B) The loss of total CD4+ T cells and central memory CD4+ T cells was monitored in the same cohorts of rhesus monkeys following SIVmac251 infection. Data are displayed two ways: dividing the monkeys into 3 cohorts as described in the legend to Fig. 2 or dividing the monkeys into 2 cohorts, one of animlas expressing only alleles 1-5 and the other of animals expressing at least 1 allele of the groups 6-11. (C) The survival of monkeys following SIVmac251 infection is shown in Kaplan-Meier (KM) curves. The P-value corresponds to the log-rank test of equality of the survival curves. The monkeys are divided into either 3 or 2 groups as described above. The comparison of the values from the groups of monkeys was analyzed using a non-parametric one-way ANOVA Kruskal-Wallis test with Dunn's multiple comparison test or the Mann-Whitney test.
###end p 42
###begin p 43
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 727 734 727 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g006">Fig. 6B</xref>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1078 1085 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000738-g006">Fig. 6C</xref>
###xml 1117 1122 1117 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1206 1213 1206 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 631 645 <span type="species:ncbi:9544">rhesus monkeys</span>
We then assessed the clinical consequences of infection in these monkeys. First, we evaluated the loss of peripheral blood total CD4+ T cells and CM CD4+ T cells in the monkeys following SIVmac251 inoculation. We sought to determine whether the expression of particular TRIM5 alleles was associated with particular immune sequelae of infection. We displayed the data in two ways: dividing the monkeys into 3 cohorts as described above and dividing the monkeys into 2 cohorts, one group of animals expressing only alleles 1-5 and the other expressing at least 1 allele of the group 6-11. The expression of TRIM5 alleles 6-11 by the rhesus monkeys was associated with a rapid loss of both total CD4+ T cells and CM CD4+ T cells (Fig. 6B). Then we assessed the effect of the expression of TRIM5 alleles 6-11 on the survival of the monkeys following infection (log-rank test of equality, Kaplan-Meyer survival curves). The monkeys expressing only alleles 1-5 maintained a statistically significant survival advantage over the monkeys expressing at least 1 allele of the group 6-11 (Fig. 6C). Therefore, the expression of TRIM5 alleles 6-11 was associated with both less efficient control of SIVmac replication in vivo and an increased rate of disease progression.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 63 66 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 558 561 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 566 569 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We demonstrated TRIM5 allele-determined relative resistance to SIV infection in vitro using both B-LCL and transduced fibroblast target cells. However, the variable resistance or permissiveness for infection was more readily apparent in the B-LCL than in the fibroblasts. This difference between target cell populations may reflect differences in TRIM5 expression under normal physiologic control in B-LCLs and in transduced CRFK cells. Thus, overexpression in CRFK cells may partially mask the relative inefficiency of some of the TRIM5 alleles to restrict SIV and HIV replication in vitro.
###end p 45
###begin p 46
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Kaslow1">[27]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Fellay1">[28]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Martin1">[29]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Dean1">[30]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Smith1">[32]</xref>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 286 291 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 356 361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A number of genes have previously been implicated in the control of HIV-1 replication. These include selected MHC class I alleles and loci, including HLA B*5701, HLA B*27 [27] and HLA C [28], as well as HLA Bw4-8OI in association with KIR3DS1 [29]. Expression of an allelic form of the HIV-1 co-receptor, the delta 32 form of CCR5, is also associated with HIV-1 containment [30]-[32]. These genes and gene loci are thought to contribute to HIV-1 control through classical immune effector mechanisms or viral entry.
###end p 46
###begin p 47
###xml 206 213 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 232 237 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 331 339 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 379 386 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 177 180 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 311 316 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 317 320 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 365 368 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 429 434 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 435 438 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The present study shows that naturally occurring TRIM5alpha B30.2(SPRY) polymorphisms affect immunodeficiency virus infections. These observations demonstrate the importance of SIV/B30.2(SPRY) interactions in vivo. The finding that TRIM5 allelic products are associated with both the permissiveness of cells to HIV-1/SIV infection in vitro and clinical sequelae of SIV infection in vivo expands the known genetic determinants of HIV-1/SIV susceptibility and implicates a novel intracellular mechanism in that virus control.
###end p 47
###begin p 48
###xml 394 398 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Mische1">[33]</xref>
###xml 399 403 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Li1">[36]</xref>
###xml 699 702 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Stremlau1">[4]</xref>
###xml 704 708 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-PerezCaballero1">[37]</xref>
###xml 709 713 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Torimiro1">[39]</xref>
###xml 297 310 <span type="species:ncbi:9544">rhesus monkey</span>
Our data suggest that the co-expression of restrictive and permissive TRIM5alpha variants results in a less effective antiretroviral state than the expression of two restrictive TRIM5alpha variants. Differences in SIVmac restriction potency and capsid binding map to the B30.2(SPRY) domain of the rhesus monkey TRIM5alpha variants. As the functional TRIM5alpha moiety is thought to an oligomer [33]-[36], co-expression of TRIM5alpha variants with different capsid-binding affinities would be expected to result in heterodimers with decreased avidity for the capsid. Dominant-negative effects of less functional TRIM5alpha variants on more potently restricting TRIM5alpha variants have been observed [4], [37]-[39].
###end p 48
###begin p 49
###xml 134 138 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Javanbakht3">[40]</xref>
###xml 139 143 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Goldschmidt1">[44]</xref>
###xml 360 364 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Javanbakht3">[40]</xref>
###xml 365 369 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-vanManen1">[43]</xref>
###xml 501 505 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Goldschmidt1">[44]</xref>
###xml 812 817 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 1286 1306 1262 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro and in vivo</italic>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 127 133 <span type="species:ncbi:9606">humans</span>
###xml 309 314 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 602 607 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 640 646 <span type="species:ncbi:9606">humans</span>
###xml 733 739 <span type="species:ncbi:9606">humans</span>
###xml 806 811 <span type="species:ncbi:9606">human</span>
###xml 1070 1083 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1218 1221 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1270 1273 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
A number of groups have evaluated the contribution of common TRIM5alpha polymorphisms to AIDS susceptibility in HIV-1-infected humans [40]-[44]. These various studies have defined associations of nsSNPs in the RING, B-box 2, Coiled-coil domains and Linker 2 region of the molecule with very modest effects on HIV-1 susceptibility and AIDS clinical progression [40]-[43]. The single SPRY domain ns SNP in human TRIM5alpha, H419Y, was also shown to have only a modest effect on these clinical endpoints [44]. The absence of evidence for a robust association between a SNP in TRIM5alpha and a substantial HIV-1-associated clinical endpoint in humans is likely a consequence of the fact that the common variant forms of this molecule in humans do not have severely impaired interactions with retroviruses. The human TRIM5 SNPs are for the most part clustered in the B-box 2 and Coiled-coil domains of the molecule, regions of TRIM5alpha that are not thought to contact the retrovirus capsid. In contrast, as we have shown in the present study, variants of TRIM5alpha in the rhesus monkey that cluster in the B30.2 (SPRY) domain of the molecule have a significant impact on the interaction of TRIM5alpha with the capsid of SIV and, as a result, exert a significant effect on SIV replication in vitro and in vivo.
###end p 49
###begin p 50
###xml 319 327 311 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 332 339 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The findings in the present study indicate that TRIM5alpha has a function beyond restricting cross-species transmission of retroviruses. We show that TRIM5alpha variants with an impaired ability to interact with the retrovirus capsid restrict pathogenic retroviruses in a susceptible host species less efficiently both in vitro and in vivo. Therefore, TRIM5alpha proteins can exert antiretroviral effects ranging from modifications of viral load to complete suppression of infection.
###end p 50
###begin title 51
Methods
###end title 51
###begin title 52
Cells
###end title 52
###begin p 53
HEK293T and feline renal fibroblasts (CRFK) were obtained from American Type Culture Collection and grown in RPMI/10% FBS.
###end p 53
###begin title 54
Recombinant viruses
###end title 54
###begin p 55
###xml 276 279 272 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Song1">[7]</xref>
###xml 560 563 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 168 173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 194 198 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 204 207 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 505 508 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 580 583 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Recombinant SIVmac239-GFP virus was produced by cotransfection of HEK293T cells with pSIVmac239Deltaenv-GFP, pVSV-G and pRev using the Lipofectamine 2000 (Invitrogen). HIV-1-GFP, SIVsmE543-GFP, EIAV-GFP, FIV-GFP, B- and N-MLV-GFP viruses were prepared as previously described [7]. At 48h after transfection, cell-free supernatant was collected. The titer of virus in the supernatant was determined by infection of HEK293T cells and assessment for % of cells expressing GFP by flow cytometric analysis. An SIV p27 antigen ELISA was performed to measure the p27 gag gene product of SIV.
###end p 55
###begin title 56
Establishment of B Lymphoblastoid Cell Lines (B-LCLs)
###end title 56
###begin p 57
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Kaur1">[45]</xref>
###xml 268 285 268 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Herpesvirus papio</italic>
###xml 60 74 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 82 96 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 248 262 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 268 285 <span type="species:ncbi:106332">Herpesvirus papio</span>
B-LCLs were generated from the same cohort of 28 uninfected rhesus monkeys and 32 rhesus monkeys previously infected with SIVmac251 as described [45]. Briefly, B cells were transformed by incubating peripheral blood mononuclear cells isolated from rhesus monkeys with Herpesvirus papio. B-LCLs were then propagated in RPMI 1640 supplemented with 20% FBS and penicillin-streptomycin.
###end p 57
###begin title 58
Sequencing of TRIM5alpha cDNA
###end title 58
###begin p 59
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. papio</italic>
###xml 212 251 208 247 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGACGAATTCCACCATGGCTTCTGGAATCCTG-3&#8242;</named-content>
###xml 266 303 262 299 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGACGTTCGAAATAGAAAGAAGGGAGACAGC-3&#8242;</named-content>
###xml 809 814 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 824 829 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 849 857 845 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000738.s001">Table S1</xref>
###xml 984 1057 976 1049 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCACCGGTGGCTCAAGCGTAGTCTGGGACGTCGTATGGGTAGCCGCCAGAGCTTGGTGAGCACAGAG-3&#8242;</named-content>
###xml 28 36 <span type="species:ncbi:106332">H. papio</span>
###xml 50 63 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 482 496 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 621 635 <span type="species:ncbi:9544">rhesus monkeys</span>
Total RNA was isolated from H. papio-immortalized rhesus monkey B-LCLs and PBMCs by using the RNeasy Mini kit (Qiagen). Untagged, full-length TRIM5alpha cDNA clones were generated by RT-PCR with primers TRIM5F1 (5'-CAGACGAATTCCACCATGGCTTCTGGAATCCTG-3') and TRIM5R1 (5'-GGACGTTCGAAATAGAAAGAAGGGAGACAGC-3') by using the SuperScript One-Step kit (Invitrogen). PCR products were cloned directly into the TOPO Blunt vector (Invitrogen). Six to 15 independent cDNA clones from individual rhesus monkeys were subjected to automated sequence analysis (GENEWIZ). Genomic DNA was isolated from lymphocytes from the same cohorts of rhesus monkeys by using QIAamp DNA kit (Qiagen), and sequenced. Primer selection was facilitated by the use of the computer program Beacon 3. Primer sequences used to amplify and sequence TRIM5 exons or TRIM5 cDNAs are shown in Table S1. To generate TRIM5alpha C-terminally tagged with hemagglutinin (HA), genes were amplified with primers TRIM5F1 and TRIM5HA-R (5'-CCACCGGTGGCTCAAGCGTAGTCTGGGACGTCGTATGGGTAGCCGCCAGAGCTTGGTGAGCACAGAG-3').
###end p 59
###begin title 60
###xml 0 13 <span type="species:ncbi:9544">Rhesus monkey</span>
Rhesus monkey B-LCL infection
###end title 60
###begin p 61
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
B-LCLs were selected for study that had previously defined TRIM5 alleles. A VSV-G pseudotyped recombinant virus constructs were used for single-round infection. 4x104 cells per well were seeded into 96-well plates and cells were infected with serial dilutions of virus by spinoculation for 2 h at 1,900xg. At 48 h after infection, these B-LCLs were evaluated for their relative susceptibility to retrovirus replication by assessing for the % of cells expressing GFP as determined by flow cytometric analysis.
###end p 61
###begin title 62
Restriction in CRFK cells expressing TRIM5 alleles
###end title 62
###begin p 63
###xml 154 157 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Stremlau1">[4]</xref>
###xml 670 671 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Feline renal fibroblast (CRFK) cells stably expressing TRIM5alpha variants encoded by allele 1, 5, 7 or 11 were generated as described by Stremlau et al. [4]. Briefly, 293T cells were co-transfected with the pLPCX vectors containing each TRIM5alpha cDNA with pVpack-GP and pVPack-VSV-G packaging plasmids (Stratagene) to produce recombinant viruses. CRFK cells were then transduced using the resulting viruses and selected in G418 (0.5mg/ml, Sigma-aldrich). For infection, CRFK cells expressing TRIM5alpha variants encoded by allele 1, 5, 7 or 11, or control cells transduced with the empty pLPCX vector were harvested and subsequently seeded into 48-well plates (1.2x104 cells per well). Cells were incubated with a VSV-G-pseudotyped recombinant virus construct for 48 h and then subjected to flow cytometric analysis.
###end p 63
###begin title 64
Immunoblotting
###end title 64
###begin p 65
###xml 385 388 <span type="species:ncbi:10116">rat</span>
###xml 397 403 <span type="species:ncbi:9986">rabbit</span>
Feline renal fibroblast (CRFK) cells were transduced as described above and harvested. Cells were then lysed in NP-40 lysis buffer (Boston BioProducts). Total protein was measured by using a BCA assay kit (Pierce) and equal amounts (20 microg) were separated by SDS/PAGE. HA-tagged TRIM5alpha was detected with either monoclonal anti-HA antibody (Roche) and HRP-conjugated either anti-rat or anti-rabbit IgG secondary antibody, respectively (Sigma-Aldrich). Levels of beta-actin were also assessed as a control for the loading of total protein by using anti-beta-actin antibody (Sigma-Aldrich).
###end p 65
###begin title 66
Capsid-binding assay
###end title 66
###begin p 67
###xml 52 68 52 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Ganser1">[22]</xref>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sup>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
###xml 170 175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 543 548 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The SIVmac239 CA-NC fusion protein was expressed in Escherichia coli and purified with minor modifications from the previously described purification method used for the HIV-1 CA-NC protein [22]. The purified SIVmac CA-NC protein was mixed with (TG)50 DNA oligonucleotides in 50 mM Tris-HCl (pH 7.0) and 500 mM NaCl solution and incubated at 37degreesC. The resulting SIVmac CA-NC complexes were negatively stained and examined under the electron microscope, confirming that the size and shape of the CA-NC complexes are very similar to those HIV-1 CA-NC complexes.
###end p 67
###begin p 68
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
Approximately 1x107 293T cells were transiently transfected to express the appropriate TRIM5 allele or with a control vector, and then harvested at 24 h post-transfection. The cells were lysed in 1 ml of hypotonic lysis buffer (10 mM Tris-HCl, pH 7.0/10 mM KCl). After brief centrifugation at 4degreesC to remove cell debris, the supernatant was spun at 110, 000xg for 1 h at 4degreesC in a Beckman ultracentrifuge. After the pre-cleaning spin, different amounts of the supernatants containing the TRIM5alpha variants were aliquoted in separate tubes and were complemented with the supernatants from the vector-transformed cells to achieve a final volume of 200 microl. To these mixtures, the same amount of SIVmac CA-NC complexes were added and the final concentration of NaCl was adjusted to 200 mM before incubation at 30degreesC for 1 h. After incubation, 20 microl of the mixtures were saved for further analysis as an input and the rest of mixtures were layered onto 60% sucrose cushion (prepared in 1x PBS) and centrifuged at 110,000xg for 1 h at 4degreesC in a Beckman ultracentrifuge. The pellet was resuspended in 1x SDS sample buffer and subjected to SDS/PAGE and Western blotting.
###end p 68
###begin title 69
Monoclonal antibody (MAb) staining of cell surface molecules and CD4+ T-lymphocyte counts
###end title 69
###begin p 70
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Sun1">[46]</xref>
Peripheral blood mononuclear cells (PBMCs) were stained with MAbs specific for cell surface molecules, including CD3, CD4, CD28, and CD95, and then subjected to flow cytometric analysis. Peripheral blood CD4+ T lymphocyte and central memory CD4+ T lymphocyte counts were calculated by multiplying the total lymphocytes count by the percentage of CD3+CD4+ T cells, and CD95+CD28+ T cells, respectively, determined by MAb staining and flow cytometric analysis [46].
###end p 70
###begin title 71
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo infection
###end title 71
###begin title 72
Animals
###end title 72
###begin p 73
###xml 101 152 101 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH Guide to the Care and Use of Laboratory Animals</italic>
###xml 14 28 <span type="species:ncbi:9544">rhesus monkeys</span>
Indian-origin rhesus monkeys used in the analysis were maintained according to the guidelines of the NIH Guide to the Care and Use of Laboratory Animals and the approval of the Institutional Animal Care and Use Committee of Harvard Medical School and the National Institute of Health.
###end p 73
###begin title 74
Challenge virus
###end title 74
###begin p 75
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000738-Letvin1">[47]</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 80 94 <span type="species:ncbi:9544">rhesus monkeys</span>
A stock of uncloned SIVmac251 was expanded on human PBMC and titered in vivo in rhesus monkeys for use in intravenous challenge studies [47]. All monkeys used in the retrospective analysis were received 1 ml of a 1:3000 dilution of this stock by intravenous route.
###end p 75
###begin title 76
Plasma viral RNA assay
###end title 76
###begin p 77
Assays were performed using an ultrasensitive branched DNA amplification assay (Bayer Diagnostics).
###end p 77
###begin title 78
Statistical analysis
###end title 78
###begin p 79
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The two-sided nonparametric Mann-Whitney test was used to determine statistical significance. Levels of P <0.05 were considered statistically significant. For multiple comparisons, non-parametric one-way ANOVA Kruskal-Wallis test was used with Dunn's multiple comparison test.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
TRIM5alpha sequencing primers used in the study
###end p 81
###begin p 82
(0.05 MB PDF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 50 55 <span type="species:ncbi:9606">Human</span>
The authors thank Professors Barton Hayes of Duke Human Vaccine Institute, and David Goldstein of Center for Population Genomics and Pharmacogenetics, Duke University, for their valuable suggestions and critical reading of this manuscript.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
###end article-title 86
###begin article-title 87
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 34 <span type="species:ncbi:9534">African green monkey</span>
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
###end article-title 87
###begin article-title 88
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 44 65 <span type="species:ncbi:11786">murine leukemia virus</span>
Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
###end article-title 88
###begin article-title 89
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
###end article-title 89
###begin article-title 90
###xml 52 75 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
###end article-title 90
###begin article-title 91
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.
###end article-title 91
###begin article-title 92
The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
###end article-title 92
###begin article-title 93
Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.
###end article-title 93
###begin article-title 94
###xml 0 14 <span type="species:ncbi:9544">Rhesus macaque</span>
Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities.
###end article-title 94
###begin article-title 95
###xml 21 35 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 75 104 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 106 109 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 164 167 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
###end article-title 95
###begin article-title 96
###xml 55 84 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.
###end article-title 96
###begin article-title 97
###xml 0 29 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 84 98 <span type="species:ncbi:9544">rhesus monkeys</span>
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.
###end article-title 97
###begin article-title 98
###xml 6 9 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 106 142 <span type="species:ncbi:11711">simian immunodeficiency virus SIVmac</span>
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
###end article-title 98
###begin article-title 99
###xml 28 42 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 72 101 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo replication.
###end article-title 99
###begin article-title 100
###xml 41 58 <span type="species:ncbi:9545">Macaca nemestrina</span>
###xml 63 82 <span type="species:ncbi:9541">Macaca fascicularis</span>
TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis.
###end article-title 100
###begin article-title 101
Evolution of a TRIM5-CypA splice isoform in old world monkeys.
###end article-title 101
###begin article-title 102
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.
###end article-title 102
###begin article-title 103
###xml 49 64 <span type="species:ncbi:9544">rhesus macaques</span>
Independent evolution of an antiviral TRIMCyp in rhesus macaques.
###end article-title 103
###begin article-title 104
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
###end article-title 104
###begin article-title 105
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 87 108 <span type="species:ncbi:11786">murine leukemia virus</span>
The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
###end article-title 105
###begin article-title 106
###xml 69 97 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.
###end article-title 106
###begin article-title 107
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Assembly and analysis of conical models for the HIV-1 core.
###end article-title 107
###begin article-title 108
Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
###end article-title 108
###begin article-title 109
###xml 111 140 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
###end article-title 109
###begin article-title 110
###xml 135 164 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 174 189 <span type="species:ncbi:9544">rhesus macaques</span>
Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques.
###end article-title 110
###begin article-title 111
###xml 108 137 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.
###end article-title 111
###begin article-title 112
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
###end article-title 112
###begin article-title 113
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A whole-genome association study of major determinants for host control of HIV-1.
###end article-title 113
###begin article-title 114
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
###end article-title 114
###begin article-title 115
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
###end article-title 115
###begin article-title 116
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
###end article-title 116
###begin article-title 117
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
###end article-title 117
###begin article-title 118
Retroviral restriction factor TRIM5alpha is a trimer.
###end article-title 118
###begin article-title 119
Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein.
###end article-title 119
###begin article-title 120
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
###end article-title 120
###begin article-title 121
The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
###end article-title 122
###begin article-title 123
The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
###end article-title 123
###begin article-title 124
A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.
###end article-title 124
###begin article-title 125
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 91 119 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
###end article-title 125
###begin article-title 126
###xml 94 100 <span type="species:ncbi:9606">humans</span>
High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans.
###end article-title 126
###begin article-title 127
###xml 72 107 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
###end article-title 127
###begin article-title 128
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
###end article-title 128
###begin article-title 129
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of common human TRIM5alpha variants in HIV-1 disease progression.
###end article-title 129
###begin article-title 130
Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques.
###end article-title 130
###begin article-title 131
###xml 61 90 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection.
###end article-title 131
###begin article-title 132
###xml 65 68 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys.
###end article-title 132
###begin p 133
The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
This work was supported by the NIAID Center for HIV/AIDS Vaccine Immunology grant AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134

